J Biomed Sci June 2021 PMID 34158025

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy.

Austin W T Chiang, Hratch M Baghdassarian, Benjamin P Kellman, Bokan Bao, James T Sorrentino, Chenguang Liang, Chih-Chung Kuo, Helen O Masson, Nathan E Lewis

Download social card

Mentions

9
Peak: 5 in Jun 2021
across 2 sources since Jun 2021

Extended reach

2,664
potential audience

Total likes

13

Video views

210

Mentions per month

Jun 2021 – Nov 2023

Where it's discussed

  • X / Twitter6 posts
  • YouTube3 videos

AI synopsis

What people are saying

The overall discussion shows positive acknowledgment of the review's contributions, with examples such as praise for its thoroughness and discussion of promising yet challenging avenues in immuno-oncology. The tone and choice of words like 'great work' and 'promises' suggest optimism about the article's importance for advancing personalized cancer therapies.

AgreementModerate agreement

Most discussions express support and recognize the importance of the research, highlighting its potential in advancing immunotherapy.

InterestModerate interest

The posts indicate a moderate level of interest, as they reference the review work and its relevance to the field, but do not delve into detailed critique or alternative views.

EngagementModerate engagement

The mentions of specific researchers and concepts like glycoimmunotherapy suggest a genuine engagement with the subject, although the interactions are mostly brief and supportive.

ImpactModerate impact

The frequent use of phrases like 'great promises,' 'challenges,' and recognition of the review's significance reflect a belief that this work could have a meaningful impact on future cancer treatments.

Abstract in brief

  • This text discusses how systems glycobiology is advancing cancer immunotherapy by understanding the role of abnormal glycosylation in tumor-immune interactions, which could lead to new drug targets and biomarkers.
  • It highlights recent progress in immunotherapy, including Nobel-winning research on immune checkpoints like CTLA4 and PD1, and emphasizes the need for more personalized treatments across different cancer types.
  • The article also explores how emerging technologies in systems glycobiology can provide deeper insights into immune responses, helping design more effective glycoimmunotherapies and improve clinical outcomes.]

Top posts

Most liked on X and Bluesky
Nathan Lewis
@Nathan_E_Lewis · X

Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" https://t.co/2qPfAr6N6w https://t.co/KvvPFpzMBu https://t.co/RXpMnN2A83

Jun 24, 2021 · 8 likes · 1 share · 1,944 followers View post →
Wan-Tien Chiang
@wtchiang2013 · X

Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" discusses the great promises and challenges in the immuno-oncology field. Great work with @hmbaghdassarian and @Nathan_E_Lewis. https://t.co/CsLF63SvRv

Jun 24, 2021 · 1 like · 1 share · 113 followers View post →
Hratch M Baghdassarian
@hmbaghdassarian · X

RT @wtchiang2013: Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunoth…

Jun 24, 2021 · 1 share · 171 followers View post →
Immuno-Oncology
@immuno_onc · X

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy https://t.co/3sHpej6rV8 https://t.co/Y59anhxhOE

Jun 23, 2021 · 115 followers View post →
Lasse Ebdrup Pedersen
@Lasse88668939 · X

RT @Nathan_E_Lewis: Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, b…

Jun 24, 2021 · 1 share · 91 followers View post →
Glycobiology_J
@glycobiology_j · X

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for #glycoimmunotherapy

Sep 5, 2023 · 13 followers View post →

All mentions

Glycobiology_J
@glycobiology_j · X

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for #glycoimmunotherapy

Sep 5, 2023 · 13 followers View post →
Lasse Ebdrup Pedersen
@Lasse88668939 · X

RT @Nathan_E_Lewis: Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, b…

Jun 24, 2021 · 1 share · 91 followers View post →
Nathan Lewis
@Nathan_E_Lewis · X

Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" https://t.co/2qPfAr6N6w https://t.co/KvvPFpzMBu https://t.co/RXpMnN2A83

Jun 24, 2021 · 8 likes · 1 share · 1,944 followers View post →
Hratch M Baghdassarian
@hmbaghdassarian · X

RT @wtchiang2013: Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunoth…

Jun 24, 2021 · 1 share · 171 followers View post →
Wan-Tien Chiang
@wtchiang2013 · X

Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" discusses the great promises and challenges in the immuno-oncology field. Great work with @hmbaghdassarian and @Nathan_E_Lewis. https://t.co/CsLF63SvRv

Jun 24, 2021 · 1 like · 1 share · 113 followers View post →
Immuno-Oncology
@immuno_onc · X

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy https://t.co/3sHpej6rV8 https://t.co/Y59anhxhOE

Jun 23, 2021 · 115 followers View post →